Boston Scientific wins CE Mark for new defibrillation lead system
BSX | Quote | Chart | News | PowerRating -- Boston Scientific, a medical device company, has announced the CE Mark and the first human implants of the company's Endotak Reliance 4-SITE defibrillation lead system.
According to Boston Scientific, the Endotak Reliance 4-SITE lead system is designed to simplify the implant procedure by combining three terminals into one integrated connector, reducing the required implant area within the body.
This system, combined with the new Teligen implantable cardioverter defibrillator (ICD) and Cognis cardiac resynchronization therapy defibrillator (CRT-D), is designed to comply with the forthcoming international connector standard. The new standard will permit product compatibility across manufacturers, the company said.
The company is working with physicians to launch the system in several phases with a focus on monitoring clinical performance through post-market analysis enhanced by the Latitude patient management system.
Fred Colen, president of cardiac rhythm management at Boston Scientific, said: "We are pleased to announce CE Mark and the first human implants of the Endotak Reliance 4-SITE lead system. This new system represents the next advance for the Endotak Reliance lead family, which has demonstrated reliability in more than 350,000 implants worldwide."
http://www.datamonitor.com
Republication or redistribution, including by framing or similar means,
is expressly prohibited without prior written consent. Datamonitor shall
not be liable for errors or delays in the content, or for any actions
taken in reliance thereon
For full details on Boston Scientific Corp (BSX) BSX. Boston Scientific Corp (BSX) has Short Term PowerRatings at TradingMarkets. Details on Boston Scientific Corp (BSX) Short Term PowerRatings is available at This Link.
- Valtech Cardio Ltd. Announces Appointment of CEO -- Medtech Veteran Bruce H. KenKnight Joins Valtech Team - 02/09/10
- BUYINS.NET: BSX, ALL, CCE, PFCB, SON, WATG Expected To Be Lower After Earnings Releases on Wednesday - 02/08/10
- Zacks Industry Outlook Highlights: Medtronic, Inc., Surgical, Inc., Boston Scientific Corporation, St. Jude Medical Inc. and Bec - 02/02/10
- Boston Scientific settles three patent disputes with Johnson & Johnson (J&J) - 02/02/10
- Boston Scientific settles patent disputes with J&J - 02/02/10
- More News >>


